Vaishali Pharma Share Price

Vaishali Pharma Share Price

NSE: VAISHALI
|
Pharmaceuticals
₹ 7.81
+₹0.04 (0.51%)
1D
Last updated 24 Jul, 2026, 15:20 IST

Vaishali Pharma Share Price Today

As of 25 Jul 2026, Vaishali Pharma share price is ₹7.81. The stock opened at ₹8.04, compared to its previous close of ₹7.77. During today's trading session, Vaishali Pharma share price moved in the range of ₹7.61 to ₹8.04, with an average price of ₹7.82 for the day. Looking at its last 52-week, the stock has touched a low of ₹4.75 and a high of ₹13.10. On the performance front, Vaishali Pharma share price has declined by 6.95% over the last six months and is down 38.12% on a year-on-year basis.

₹7.61
0.51% up today
₹8.04
1D LOW
1D HIGH

Vaishali Pharma Returns Calculator

Circuit
L
H
₹6.99
₹8.53
52-week
L
H
₹4.75
₹13.10
Mkt Cap Cr
101.24
P/E
24.28
P/B
1.47
ROE
6.03%
D/E
0.27
ROCE
8.35%
Div. Yield
0.00%
EPS(TTM)
0.31
Turnover
1.45
EV/EBITDA
15.11
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.28%
Quick Ratio
0.00
Curr. Ratio
3.22
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vaishali Pharma outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Vaishali Pharma appears to be fairly valued compared to its peers
Step 2 of 5
Earnings
Poor
Vaishali Pharma earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

Vaishali Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue112.61
Operating profit5.39
Net profit4.03

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹99.03₹86.28₹69.66₹75.82
Other Income₹3.21₹2.03₹2.23₹1.79
Total Revenue₹102.23₹88.31₹71.89₹77.61
Total Expenses₹101.01₹87.39₹63.05₹71.88
Profit Before Tax₹1.23₹0.93₹8.85₹5.73
Tax₹0.41₹0.21₹2.24₹1.70
Profit After Tax₹0.82₹0.72₹6.60₹4.02
EPS - Basic₹0.06₹0.68₹6.26₹3.82
EPS - Diluted₹0.06₹0.64₹5.91₹3.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.23₹0.93₹8.85₹5.73
Income before WC changes₹8.13₹6.78₹10.01₹7.35
Change in Assets-₹35.08₹2.54₹4.00₹7.09
Change in Liabilities₹9.26-₹6.23-₹11.36-₹12.29
Change in WC-₹25.82-₹3.70-₹7.36-₹5.20
Cash flow from Operations-₹18.04₹0.81₹1.08₹1.32
Cash flow from Investing-₹0.19₹1.20₹0.28-₹0.85
Cash flow from Financing₹18.49-₹1.42-₹1.73₹0.42
Total Cash Flow₹0.26₹0.59-₹0.37₹0.89
Cash (Start of the year)₹1.58₹0.98₹1.36₹0.47
Cash (End of the year)₹1.84₹1.58₹0.98₹1.36

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹5.36₹5.44₹6.23₹5.20
Current Assets₹104.48₹74.52₹72.67₹76.43
Total Assets₹109.84₹79.96₹78.90₹81.62
Current Liabilities₹40.05₹33.08₹32.07₹51.94
Net Current Asset₹64.43₹41.44₹40.60₹24.49
Non-Current Liabilities₹4.88₹4.03₹6.30₹3.33
Equity Capital₹64.92₹42.84₹40.53₹26.35
Total Equity & Liabilities₹109.84₹79.96₹78.90₹81.62
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
56.29
Neutral
ATR (14)
0.41
Neutral
STOCH(9,6)
36.76
Neutral
STOCH RSI (14)
47.9
Neutral
ADX(9)
15.1
Bullish
UO(9)
44.23
Neutral
ROC(12)
4.44
Bullish
WillR(14)
-39.09
Neutral
Period
Simple value
Exponential vaue
5D
7.83
7.81
10D
7.83
7.76
20D
7.58
7.64
50D
7.33
7.45
100D
7.08
7.48

About Vaishali Pharma

Vaishali Pharma Share Price
ISIN
INE972X01022
Sector Market Cap
₹ 101.24 Cr

Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.

Vaishali Pharma Financial Highlights

  • Revenue: Vaishali Pharma reported revenue of ₹112.61 crore in FY26 vs ₹102.24 crore in FY25. It showed an increase of 10.14% on a yearly basis.
  • Operating Profit: Vaishali Pharma reported an operating profit of ₹5.39 crore in FY26 vs ₹1.23 crore in FY25. It showed an increase of 338.21% on a year-on-year basis.
  • Net Profit: Vaishali Pharma reported a net profit of ₹4.03 crore in FY26 vs ₹0.82 crore in FY25. It showed an increase of 391.46% on a yearly basis.

Vaishali Pharma Quarterly Result Highlights

  • Vaishali Pharma reported revenue of ₹28.19 crore in Mar 2026, compared with ₹25.54 crore in Dec 2025, representing an increase of 10.38% on a quarter-on-quarter (QoQ) basis.
  • Vaishali Pharma reported an operating profit of ₹0.18 crore in Mar 2026, compared with ₹1.82 crore in Dec 2025, representing a decrease of 90.11% on a quarter-on-quarter (QoQ) basis.
  • Vaishali Pharma reported a profit of ₹0.29 crore in Mar 2026, compared with ₹1.30 crore in Dec 2025, reflecting a decrease of 77.69% on a QoQ basis.
Know more
Promoters
30.54%
FII
0.00%
Other DII
0.00%
Retail and other
69.46%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Vaishali Pharma Share Price
Vaishali Pharma
Pharmaceuticals
Add Stock
Add Another

FAQs on Vaishali Pharma Share Price